Women in STEM 2022
Meet three of Boehringer Ingelheim's female scientists and learn why and how women are making a difference in STEM.
Search
Drug Discovery at Boehringer Ingelheim
Find out more about the drug discovery process at Boehringer Ingelheim
Our Contribution
Humanity is facing serious challenges. We believe we can always do more – for ourselves and for the generations to come.
Vetmedin®
Treatment of canine congestive heart failure originating from dilated cardiomyopathy or valvular insufficiency (mitral and/or tricuspid regurgitation).
“LastMile” – improving through digital
“LastMile” – improving through digital
Winners of 2020 BVDzero Case Awards announced
Winners of 2020 BVDzero Case Awards announced
Our Commitment
We want to create value in areas of unmet medical need and engage with communities and society to improve lives – for humans and animals.
Our Commitment to Stop Rabies
Through our Stop Rabies program, we are committed to education, vaccination, and surveillance, working alongside local governments, health authorities, veterinarians, and communities to eliminate Rabies.
Europe needs a vibrant research eco-system
At this week's EFPIA Days in Brussels, stakeholders will discuss how to re-establish a research-friendly eco-system in Europe.
Is artificial intelligence the future of farming?
Mexico rabies free dog vaccination campaigns
Mexico: a champion in the fight against rabies. The first country in the world to be declared free from dog-transmitted rabies.
Boehringer Ingelheim donates 75,000 doses of rabies vaccine
This significant rabies vaccine donation will support GARC’s efforts to address deaths due to rabies in Madagascar.
COVID-19 Protecting Our Employees
Meet BIs Brains Michael Sand
Dr. Michael Sand, Senior Clinical Program Leader, CNS at Boehringer Ingelheim shares his view on the complexities of the CNS research landscape.
China pioneers biosecurity report against ASF
Boehringer Ingelheim compiles data from 1,000 swine farms into the first market report on biosecurity. Document sheds light on livestock management and contributes to the fight against African swine fever.
“Rapid progress towards clinical candidates”
Boehringer Ingelheim forms a joint venture to create the next generation of antimicrobials.
Leading experts shed light on importance of establishing dedicated stroke management centers
Leading experts shed light on importance of establishing dedicated stroke management centers across healthcare facilities
COVID-19: Research Update
Boehringer Ingelheim stops treatment with experimental medication in study investigating benefits for severely ill patients with COVID-19
Championing novel science
Dr. Vikas Mohan Sharma announces FDA fast-track designation for BI 1358894 as potential treatment for Borderline Personality Disorder.
EMPRISE
Learn about the EMPRISE real-world evidence study and use of empagliflozin in routine clinical care
COVID-19 Ivermectin Animal Health Not for Human Use
Boehringer Ingelheim manufactures several veterinary products containing ivermectin. They are not approved or suitable for use in humans to try to prevent or treat COVID-19.
Listen to the sounds disrupting farms worldwide
A pioneer in Precision Livestock Farming, Prof. Daniel Berckmans reveals how online monitoring technology is bringing healthier pigs closer to farmers and consumers
First hospital uae and gcc receive international award stroke management
Ibrahim Bin Hamad Obaidullah Hospital Receives the Diamond Award from the World Stroke Organization
Drugging Cancers Big Four
What does it mean to drug cancer’s “big four”? Learn how Darryl McConnell & his team are tackling one of the biggest scientific conundrums.
Boehringer Ingelheim Brings Hundreds of Leading Cardiologists from Eight Countries Together
Boehringer Ingelheim Brings Hundreds of Leading Cardiologists from Eight Countries Together